1. Home
  2. PZZA vs VOR Comparison

PZZA vs VOR Comparison

Compare PZZA & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Papa John's International Inc.

PZZA

Papa John's International Inc.

N/A

Current Price

$22.60

Market Cap

1.2B

ML Signal

N/A

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

N/A

Current Price

$24.72

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PZZA
VOR
Founded
1984
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
PZZA
VOR
Price
$22.60
$24.72
Analyst Decision
Buy
Buy
Analyst Count
8
10
Target Price
$45.00
$45.33
AVG Volume (30 Days)
1.7M
716.6K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
5.25%
N/A
EPS Growth
N/A
N/A
EPS
0.46
N/A
Revenue
$2,068,421,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$49.20
N/A
Revenue Growth
14.07
N/A
52 Week Low
$22.42
$1.90
52 Week High
$55.74
$49.95

Technical Indicators

Market Signals
Indicator
PZZA
VOR
Relative Strength Index (RSI) 28.63 59.37
Support Level N/A $21.83
Resistance Level $24.25 $24.44
Average True Range (ATR) 0.66 1.01
MACD 0.20 -0.11
Stochastic Oscillator 13.92 71.38

Price Performance

Historical Comparison
PZZA
VOR

About PZZA Papa John's International Inc.

Papa John's International Inc operates and franchises pizza delivery and carryout restaurants and, in certain international markets, dine-in and delivery restaurants. It has four defined reportable segments: Domestic Company-owned restaurants, North America franchising, North America commissaries, and International. The company derives maximum revenue from North America commissaries segment. The North America commissaries segment consists of the operations of its regional dough production and product distribution centers in the United States and Canada and derives its revenues principally from the sale and distribution of food and paper products to Domestic Company-owned and franchised restaurants in the United States and Canada.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: